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T-tests and multivariate linear regression models were conducted to compare
cotinine levels between comparison groups.
Result: Males and females were equally represented, with a mean age of
45.8 yrs (SD=12.6 years). Cigarette smokers had significantly higher co-
tinine levels (1477.4±1602 ng/ml) than non-smokers (57.6±155.2 ng/ml,
p=0.02), and passive smokers (spouses of smokers) levels were intermedi-
ate (940.6±1719 ng/ml). Tobacco chewers had the highest cotinine levels of
all groups (2779.9±2591 ng/ml) and the significant difference persisted after
adjustment for age, sex, body mass index, and physical activity (p
Conclusion: This is one of the first studies evaluating cotinine levels for
smokeless tobacco in 24-hour urine samples in India. These findings require
replication and suggest that combating nicotine dependency in chewers may be
more difficult than in other tobacco users.
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Background: Smoking is the dominant form of tobacco globally. However in
Asian countries like China, India and Indonesia which share the maximum bur-
den of tobacco use, the use of smokeless form of tobacco is common. The
adverse health and economic effect of smokeless tobacco is as harmful as that
of smoking. In India, 75% of the tobacco users were smokeless tobacco users
(SLT). Limited information is available at the population level on smokeless
tobacco as a smoking cessation aid in India.
Objective: The present study examines the tobacco transition with specific em-
phasis on switching over to smokeless tobacco as a smoking cessation method
among adults in India.
Method: We used raw data on the nationally representative household survey
Global Adult Tobacco Survey (GATS) 2009–2010 India for the present study. We
studied the smoking cessation method for those who quit smoking within 1 year.
Result: Prevalence of smokeless tobacco was nearly two times higher than that
of smoking in India. The exclusive smokeless tobacco use was three time high
than that of smoking prevalence. Quit ratio was low among smokeless tobacco
users (5%) compared to smokers (13%). SLT use was more prevalent in rural
area (29%) compared to their urban counterparts (18%). Among former smokers
(ever-smokers who stopped smoking within one year) 20% switched to smokeless
tobacco as a smoking cessation method. Men were five times higher switching
to SLT than women (OR 4.81, 95% CI 4.76–4.87). Youth (15–24 years) (OR 1.59,
CI 1.57–1.60) educated (OR 4.14, CI 4.11–4.17) and employed (OR 10.8, CI
10.66–10.94) adults were more likely to switching to smokeless tobacco as a
smoking cessation aid.
Conclusion: The recent transition from smoking to smokeless tobacco use in
India is remarkable and relevant to the global discussion for further studies
and has implications for tobacco control policies in India. The low quit rate
among smokeless tobacco users and a high proportion of smokers switching to
smokeless tobacco predicts the future burden of SLT in India.
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Background: Previous reviews on the health effects of smokeless tobacco
have included Swedish snus, which is known to be less harmful than conven-
tional products, and preparations containing betel nut which is independently
carcinogenic.
Objective: This systematic review seeks to determine risk of oral squamous
cell carcinoma (OSCC), leukoplakia, periodontal disease, pancreatic cancer
and adverse foetal outcomes in users of non-snus smokeless tobacco products
(NSST).
Method: Systematic review and meta-analysis was conducted in accordance
with Meta-analysis of Observational Studies in Epidemiology (MOOSE) guide-
lines. Pooled odds ratios and 95% confidence intervals were estimated by
using random-effect models. We searched Medline, Embase and PsycInfo; no
language restrictions were imposed. The primary outcomes were OSCC, leuko-
plakia, periodontal disease, pancreatic cancer and adverse foetal outcomes.
All forms of smokeless tobacco from different countries, except snus and the
ones containing betel nut, were considered as exposures.
Result: A total of 25 studies from 7 different countries were included, of which
19 could be included in the meta-analysis. NSST was significantly associated
with an increased risk of leukoplakia (OR=13.46; 95% CI: 4.29 to 42.25; I2=98%)
and nearly doubled the risk of OSCC (OR=1.84; 95% CI: 0.83 to 4.07; I2=95%).
However, NSST use had no significant effect on the risk of pancreatic cancer
(OR=1.04; 95% CI: 0.47 to 2.32; I2=59%). Adverse fetal outcomes were only
considered in one study which found that NSST use during pregnancy decreased
mean birth weight of the infant by 17.1g (95% CI: 103 to 69). It was not possible
to calculate pooled estimates for studies considering periodontal disease due
to insufficient data.
Conclusion: NSST users are at significantly increased risk of OSCC and leuko-
plakia however no association was detected with pancreatic cancer. Few stud-
ies have been performed on other systemic diseases, in particular relating to
pregnancy outcomes. The findings of this meta-analysis reaffirm the vastly
heterogeneous nature of smokeless tobacco products around the world. Despite
the exclusion of potential confounding factors (South Asian products containing
betel nut) and products with markedly different manufacturing processes (snus
from Sweden), extreme levels of heterogeneity were observed which makes
it critical for future global research on smokeless tobacco to identify a firm
means of classifying and assimilating evidence on smokeless tobacco.
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Background: The WHO South-East Asia and Western Pacific Regions have a
combined 680 million tobacco smokers, and within the South-East Asia Region
alone there are an additional 250 million smokeless tobacco users. Many coun-
tries have started to implement effective tobacco demand reduction measures.
However, as countries enforce smoke-free legislation, and raise tobacco taxes
(focussing in most cases on manufactured cigarettes) tobacco companies have
started to shift to marketing smokeless tobacco products and/or other forms of
tobacco not affected by the increase of prices.
Objectives: To describe prevalence of use, market-size, and cost of “other
tobacco products” relative to manufactured cigarettes in eight countries that
have conducted the Global Adult Tobacco Survey.
Methodology: This study examines findings from Global Adult Tobacco Surveys
conducted in eight countries (Bangladesh, China, India, Indonesia, Malaysia,
Philippines, Thailand, and Vietnam) to determine the prevalence of a variety
of other tobacco product use (defined and non-manufactured cigarettes). Re-
cent trends in market growth of other tobacco products, along with price and
taxation data, were also analysed where this information was available.
Results: While the types of other tobacco product use varies between coun-
tries, prevalence of use of these products represents a significant proportion
of overall tobacco use in several of the countries studied. Analyses of avail-
able tax data has shown that several of the products looked at were taxed at
significantly lower rates than manufactured cigarettes.
Conclusions: Other tobacco product use represents a significant portion of
the tobacco-related health burden in several countries in South-East Asia. The
findings of this study point to a need for improved surveillance to better identify
trends in the use of other tobacco products, and for policies to reduce demand
for these products.
The political landscape for the tobacco endgame
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Background: Unlike other producers of unhealthy commodities, tobacco com-
panies are now widely viewed as vectors of disease, with whom partnership
approaches are recognised as unacceptable in policy and in science and from
whom voluntary initiatives are seen as inadequate. The fundamental conflict of
interest between the tobacco industry and health receives unique recognition
in Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC),
under which states must protect the development of public health policies from
tobacco industry interference. Yet the extent to which parties are committed
to implementing Article 5.3 can appear questionable.
Method: We examined FCTC implementation reports from 161 countries to
assess country perceptions of the extent of implementation of Article 5.3 and
of tobacco industry interference as a barrier to FCTC implementation.
Result: Overall, 54% of FCTC parties report having adopted and implemented
programmes to protect tobacco control policies from the vested interests of
the tobacco industry. This figure masks substantial variation when countries
are organized by World Bank income categories; only one third of low income
countries and under half of high income countries report implementing such
programmes. Variation is more pronounced across WHO regions; whereas al-
most three quarters of countries from the Eastern Mediterranean Region claim
to have implemented such measures, almost two thirds of the African Region
report no such progress. Fewer countries claim to have implemented measures
to ensure public access to information on industry activities; three quarters of
both low- and high-income countries report no such measures. Comments pro-
vided within the implementation reports suggest low compliance with specific
recommendations made in the implementation guidelines for Art. 5.3. Only
9 countries identified Art. 5.3 as a priority for further FCTC implementation,
while one fifth of parties identified tobacco industry interference and tactics
as barriers to implementation more broadly.
Conclusion: The successful implementation of Art. 5.3 is widely recognised
